Abstract
The aim of this study is to summarize available knowledge about common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. A literature search was carried out by using MEDLINE and references of selected articles. The search included articles published up to March 2008. The main genetic finding concerns the serotonin transporter gene promoter polymorphisms, the long variant of which seems to be related to a positive response to therapy in mood disorders and could also have a role in the treatment of anxiety disorders. Among other predictors, the main factors common to both classes of disorder are comorbid axis II disorders and early onset of illness, which are related to a worse response to therapy and concomitant good physical conditions, absence of earlier treatments, early administration and response to therapies, and higher setfdirectedness, which is related to a better outcome. Many common predictors have been identified and these seem to be related to features covering the totality of patients that go beyond specific characteristics of single disorders. Possible limitations and suggestions for future research based on a more integrated vision of human complexity are discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 1-18 |
| Number of pages | 18 |
| Journal | International Clinical Psychopharmacology |
| Volume | 24 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2009 |
Fingerprint
Keywords
- Antidepressants
- Anxiety disorders
- Anxiolytic drugs
- Clinical factors
- Genetic factors
- Mood disorders
- Predictors of response
ASJC Scopus subject areas
- Psychiatry and Mental health
- Pharmacology (medical)
Cite this
Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. / Serretti, Alessandro; Chiesa, Alberto; Calati, Raffaella; Perna, Giampaolo; Bellodi, Laura; De Ronchi, Diana.
In: International Clinical Psychopharmacology, Vol. 24, No. 1, 01.2009, p. 1-18.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders
AU - Serretti, Alessandro
AU - Chiesa, Alberto
AU - Calati, Raffaella
AU - Perna, Giampaolo
AU - Bellodi, Laura
AU - De Ronchi, Diana
PY - 2009/1
Y1 - 2009/1
N2 - The aim of this study is to summarize available knowledge about common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. A literature search was carried out by using MEDLINE and references of selected articles. The search included articles published up to March 2008. The main genetic finding concerns the serotonin transporter gene promoter polymorphisms, the long variant of which seems to be related to a positive response to therapy in mood disorders and could also have a role in the treatment of anxiety disorders. Among other predictors, the main factors common to both classes of disorder are comorbid axis II disorders and early onset of illness, which are related to a worse response to therapy and concomitant good physical conditions, absence of earlier treatments, early administration and response to therapies, and higher setfdirectedness, which is related to a better outcome. Many common predictors have been identified and these seem to be related to features covering the totality of patients that go beyond specific characteristics of single disorders. Possible limitations and suggestions for future research based on a more integrated vision of human complexity are discussed.
AB - The aim of this study is to summarize available knowledge about common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. A literature search was carried out by using MEDLINE and references of selected articles. The search included articles published up to March 2008. The main genetic finding concerns the serotonin transporter gene promoter polymorphisms, the long variant of which seems to be related to a positive response to therapy in mood disorders and could also have a role in the treatment of anxiety disorders. Among other predictors, the main factors common to both classes of disorder are comorbid axis II disorders and early onset of illness, which are related to a worse response to therapy and concomitant good physical conditions, absence of earlier treatments, early administration and response to therapies, and higher setfdirectedness, which is related to a better outcome. Many common predictors have been identified and these seem to be related to features covering the totality of patients that go beyond specific characteristics of single disorders. Possible limitations and suggestions for future research based on a more integrated vision of human complexity are discussed.
KW - Antidepressants
KW - Anxiety disorders
KW - Anxiolytic drugs
KW - Clinical factors
KW - Genetic factors
KW - Mood disorders
KW - Predictors of response
UR - http://www.scopus.com/inward/record.url?scp=58349108113&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58349108113&partnerID=8YFLogxK
U2 - 10.1097/YIC.0b013e32831db2d7
DO - 10.1097/YIC.0b013e32831db2d7
M3 - Article
VL - 24
SP - 1
EP - 18
JO - International Clinical Psychopharmacology
JF - International Clinical Psychopharmacology
SN - 0268-1315
IS - 1
ER -